Estrogen Receptor + Progesterone Receptor + HER-2/neu
AED3,450.00
Sample Type : Paraffin Embedded Block/Charged Slides
Methodology : Immunohistochemical
TAT : 7 Days
Description
**Estrogen Receptor Progesterone Receptor HER-2/neu Test**
The Estrogen Receptor Progesterone Receptor HER-2/neu test is a specialized diagnostic tool designed to evaluate the presence and expression levels of estrogen receptors (ER), progesterone receptors (PR), and HER-2/neu proteins in tissue samples. This test is essential for diagnosing, monitoring, and planning treatment for hormone receptor-positive and HER-2/neu-positive cancers, particularly breast cancer. By providing critical insights into the molecular profile of tumors, it enables personalized and targeted therapeutic strategies, making it a vital resource for oncologists, pathologists, and researchers.
**Why You Need This Test**
This test plays a crucial role in the diagnosis and management of breast cancer and other hormone receptor-related cancers. It helps determine whether a tumor is driven by hormones or growth factors, which directly impacts treatment decisions. For example, patients with ER or PR-positive tumors may benefit from hormone therapies like tamoxifen or aromatase inhibitors, while those with HER-2/neu-positive tumors may require targeted therapies such as trastuzumab. By identifying these biomarkers, the test ensures that patients receive the most effective and personalized treatment, improving outcomes and reducing unnecessary interventions.
**Symptoms That Indicate This Test**
This test is recommended for individuals experiencing symptoms or conditions that may indicate hormone receptor-positive or HER-2/neu-positive cancers. These include:
– A palpable lump in the breast or underarm area.
– Changes in breast size, shape, or appearance.
– Nipple discharge or inversion.
– Persistent breast pain or tenderness.
– Skin changes on the breast, such as dimpling or redness.
– A family history of breast cancer or genetic predisposition.
– Recurrence of breast cancer or progression despite initial treatment.
**Natural Production**
Estrogen and progesterone are hormones naturally produced by the ovaries, adrenal glands, and, during pregnancy, the placenta. These hormones regulate various physiological processes, including the menstrual cycle and reproductive health. HER-2/neu is a protein involved in cell growth and repair, naturally expressed in small amounts in healthy cells. However, abnormal levels of these markers can indicate the presence of hormone receptor-positive or HER-2/neu-positive cancers. Factors such as age, hormonal changes, genetic mutations, and environmental influences can affect their levels, making this test critical for accurate diagnosis and treatment planning.
**What Happens If Untreated**
Ignoring abnormal results from this test can lead to significant health risks. Untreated hormone receptor-positive or HER-2/neu-positive cancers may progress rapidly, spreading to other parts of the body and becoming more difficult to treat. Delayed diagnosis can result in limited treatment options, reduced effectiveness of therapies, and a poorer prognosis. Early detection through this test allows for timely intervention, improving survival rates and quality of life.
**How to Prepare for the Test**
Preparation for this test is straightforward. Patients should provide a paraffin-embedded tissue block or charged slides from a biopsy or surgical specimen. No additional preparation, such as fasting or medication adjustments, is typically required. However, it is essential to consult with your healthcare provider for specific instructions based on your medical history.
**Test Overview**
– Sample Type: Paraffin Embedded Block or Charged Slides.
– Methodology: Immunohistochemical (IHC) analysis.
– Turnaround Time (TAT): 7 days.
This test uses advanced immunohistochemical techniques to detect and quantify ER, PR, and HER-2/neu expression levels with high sensitivity and specificity. Results are delivered within seven days, ensuring timely information for clinical decision-making.
**Call to Action**
Take control of your health today by booking the Estrogen Receptor Progesterone Receptor HER-2/neu test. Whether you are seeking a diagnostic test near you or looking to buy a lab test online, this comprehensive analysis provides the critical insights needed for effective cancer diagnosis and treatment planning. Don’t wait—schedule your test now and empower yourself with the knowledge to make informed decisions about your health.
**Cytology/Histopathology**
This test is categorized under Cytology/Histopathology, making it an essential component of diagnostic workflows in pathology labs and cancer research facilities.
Reviews
There are no reviews yet.